On-Demand Webinars
-
Faster Clones, Simpler Process: What's Changing In CHO Expression?
6/3/2026
This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.
-
How Solid-State Science Solves Your Toughest API Challenges
6/3/2026
Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.
-
Building A Successful ICH Stability CoE Collaborating At Scale
6/3/2026
Building an ICH Stability CoE takes more than outsourcing. Learn how strategic collaboration, operational excellence, and shared goals drive long-term partnership value.
-
Process Development And Intensification For UF/DF Of Viral Vectors
6/3/2026
Optimizing TFF in viral vector workflows can reduce processing time while improving yield. Comparing TMP and permeate control strategies highlights key trade-offs to guide your purification decisions.
-
Accelerate Drug Development Through Strategic, Integrated Partnerships
6/3/2026
Your next development partner could determine your program's success. Learn how leading biotech and pharma organizations use integrated partnerships to speed development and strengthen pipeline value.
-
Challenges And Opportunities With Novel AAV Capsids
6/2/2026
Explore challenges and solutions in developing novel AAV capsids, focusing on manufacturing complexity, analytical testing, and regulatory considerations for advancing gene therapy effectiveness.
-
Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing
6/2/2026
See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.
-
From Complexity To Confidence: Supporting Tech Transfer With A Prefillable Syringe System
6/2/2026
Discover how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.
-
Early Decisions, Late-Stage Consequences: How The '3S's' Determine Development Success
6/2/2026
Gain actionable insights into how a proactive 3S approach can reduce development risks, streamline scale-up, and position your drug product for a smoother path to commercialization.
-
Quality By Design: The Future Of Automated Pharmaceutical Labeling
5/28/2026
Learn how applying Quality by Design principles to automated labeling platforms utilizes robotics to eliminate manual errors and seamlessly adapt to future pharmaceutical packaging formats.